Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-182901
Filing Date
2021-06-04
Accepted
2021-06-04 16:06:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7533
  Complete submission text file 0001193125-21-182901.txt   8443
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations